A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer

By Garst Jennifer  

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 257-266

Adis International

Access to resources Recommend Favorite

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

By James Jehana   Murry Daryl   Treston Anthony   Storniolo Anna   Sledge George   Sidor Carolyn   Miller Kathy  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 41-48

Springer Publishing Company

Access to resources Recommend Favorite

Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors

By Medioni Jacques   Huchon Cyrille   >  

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

By Moulder Stacy   Dhillon Navneet   Ng Chaan   Hong David   Wheler Jennifer   Naing Aung   Tse Susan   La Paglia Amy   Dorr Robert   Hersh Evan   Boytim Michelle   Kurzrock Razelle  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 634-640

Springer Publishing Company

Access to resources Recommend Favorite